Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich Corporation (SIAL - Analyst Report), has clinched commercial sales and licensing contracts from two premier Asian biopharmaceutical companies. The agreement is for the sale and licensing of CHOZN, the off-the-shelf cell line Bioproduction platform, to the Asian biopharmaceutical developers. This strengthens SAFC’s biopharmaceutical market presence in Asia.

The CHOZN Platform is featured as a prime component of customers' global biotherapeutic commercialization strategy in these contracts. The CHOZN Platform comprises the CHOZN GS-/- CHO cell line and an optimized set of cGMP-produced, chemically defined (CD) media and feeds specifically geared for the cell line to maximize the production of monoclonal antibodies and other r-proteins.

The CHOZN GS (-/-) platform provides a stable cell line that accelerates selection and scale-up of high-producing clones for the production of recombinant protein drugs by conserving weeks of development. CHOZN, along with Sigma-Aldrich's CompoZr Zinc Finger Nuclease (ZFN) technology, provides a gateway from development through commercialization.

SAFC also provides worldwide user support along with cell line, media and feed. SAFC works with customers on building protocols from transfection through to scale-up in bioreactors, as well as providing comprehensive cell line safety testing and development history packages.  Moreover, the CD media and feed system allows for tunable product quality.

Sigma-Aldrich expects to widen its foothold in Asia based on its ability to speed up upstream development timelines to favorably impact the potential profitability of biotherapeutic products.

Sigma-Aldrich currently maintains a Zacks Rank #4 (Sell).

Other companies in the specialty chemical space with favorable Zacks Rank are OM Group Inc. (OMG - Snapshot Report), American Vanguard Corp. (AVD - Snapshot Report) and Ferro Corp. (FOE - Snapshot Report). While OM Group and American Vanguard hold a Zacks Rank #1 (Strong Buy), Ferro Corp retains a Zacks Rank #2 (Buy).
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%